The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.

Re: Programmatic and research targets for the Global Plan to Stop TB, 2016–2020

On World TB Day, members of the global childhood TB community sent an open letter to the World Health Organization requesting they include the number of children under the age of five and the number of children with HIV started on preventive TB therapy in the annual Global Tuberculosis Report by 2016.

Community groups sent public comments in support of the addition of rifapentine, delamanid, bedaquiline and linezolid to the WHO Model List of Essential Medicines.

An open letter requests that The Union take steps to retire the use of stigmatizing and criminalizing terminology from the papers published in its journals and the abstracts submitted to its conferences.

We are pleased to announce the completed renovation of TB Online – a website for activists, patients, healthcare workers, and researchers to learn more about tuberculosis (TB).

Several community groups express concerns regarding the STREAM stage II trial design for bedaquiline approval.

Re: Ensuring the fair administration of the Kochon Prize

Community groups express concern for AstraZeneca's departure from tuberculosis and urge the company to ensure continued investment in the field.

Comment on Guidance for industry on pulmonary tuberculosis: Developing drugs for treatment.